Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Annual Rutgers Health Faculty Development Symposium – TOMORROW 6/19
- Losing weight in middle age could reduce chronic diseases later, study shows.
- Weill Cornell-Rutgers Health NeuroHIV Research Symposium II on July 8th
- Rutgers University research continues to put New Jersey on the map.
- Are synthetic food dyes unsafe? Experts reveal what the research really shows.
Categories
- Community (2,284)
- Covid (987)
- CTO Events (6)
- News (2,909)
- Pilots (21)